Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Agarwal Arjun. Insider active across 1 company, notably Oruka Therapeutics, Inc.. Aggregated, 23 filings have been logged. Breakdown: 0 buy · 16 sells. Total volume traded: €1.7m. Activity tracked since 23 January 2026. The latest transaction was disclosed on 13 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Agarwal Arjun
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
8,542 shares@ US$12.50Common StockSEC:0000907654-26-000075:0
1,458 shares@ US$34.39Common StockSEC:0000907654-26-000075:1
2,100 shares@ US$104.6734Common StockSEC:0000907654-26-000075:2
2,132 shares@ US$105.5716Common StockSEC:0000907654-26-000075:3
1,268 shares@ US$106.6255Common StockSEC:0000907654-26-000075:4
2,142 shares@ US$107.7138Common StockSEC:0000907654-26-000075:5
2,358 shares@ US$108.4628Common StockSEC:0000907654-26-000075:6
8,541 shares@ US$12.500.0020% mcap10.5% of flowCommon StockSEC:0000907654-26-000071:0
1,458 shares@ US$34.390.0010% mcap4.9% of flowCommon StockSEC:0000907654-26-000071:1
300 shares@ US$83.06650.0005% mcap2.4% of flowCommon StockSEC:0000907654-26-000071:2
3,743 shares@ US$84.25570.0060% mcap30.9% of flowCommon StockSEC:0000907654-26-000071:3
5,656 shares@ US$84.90120.0091% mcap47.1% of flowCommon StockSEC:0000907654-26-000071:4
300 shares@ US$85.63330.0005% mcap2.5% of flowCommon StockSEC:0000907654-26-000071:5
888 sharesCommon StockSEC:0000907654-26-000066:0
699 sharesCommon StockSEC:0000907654-26-000066:1
8,000 sharesCommon StockSEC:0000907654-26-000064:0
1,459 sharesCommon StockSEC:0000907654-26-000064:1
1,859 sharesCommon StockSEC:0000907654-26-000064:2
4,340 sharesCommon StockSEC:0000907654-26-000064:3
3,260 sharesCommon StockSEC:0000907654-26-000064:4
395 sharesCommon StockSEC:0000907654-26-000064:5
395 shares@ US$41.30100.0% of flowCommon StockSEC:0000907654-26-000032:0
17,500 shares0Common StockSEC:0000907654-26-000016:0
About Agarwal Arjun
Arjun Agarwal is Senior Vice President, Finance at Oruka Therapeutics, Inc. He has filed 16 forms in total, and across the 16 recent sampled filings between 2026-01-23 and 2026-07-13, the most common transaction type is sale, with EUR 756705 of sales and EUR 0 of purchases.